Stock

Nasdaq:

DEPO

Price:

3.86 +0.00

Volume:

0

20 minute delay

In The News

September 9, 2010 Depomed to Present at the Rodman & Renshaw 12th Annual Healthcare Conference

August 11, 2010 Depomed Reaches SPA Agreement With FDA for Phase 3 Hot Flash Trial

August 5, 2010 Depomed Licenses GLUMETZA(R) Data and Acuform(R) Technology

August 5, 2010 Depomed Reports Second Quarter 2010 Financial Results

August 3, 2010 Depomed Receives Confirmation from Pfizer That No Infringement Suit to be Filed on DM-1796 NDA